Evaluation of cannabimimetic effects of structural analogs of anandamide in rats

European Journal of Pharmacology

Volumn 355, Issue 2-3, 1998, Pages 113-118

  Wiley, Jenny L ^a   Ryan, William J ^b   Razdan, Raj K ^b   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Organix   (United States)

Author keywords

9 Tetrahydrocannabinol; Anandamide; Cannabinoid; Drug discrimination

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DRONABINOL;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG RECEPTOR BINDING; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; DISCRIMINATION (PSYCHOLOGY); MALE; MORPHOLINES; NAPHTHALENES; POLYUNSATURATED ALKAMIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0031665875     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00502-0     Document Type: Article

References (22)

1. Adams, I.B., Ryan, W., Singer, M., Razdan, R.K., Compton, D.R., Martin, B.R., 1995a. Pharmacological and behavioral evaluation of alkylated anandamide analogs. Life Sci. 56, 2041-2048.
2. Adams, I.B., Ryan, W., Singer, M., Thomas, B.F., Compton, D.R., Razdan, R.K., Martin, B.R., 1995b. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273, 1172-1181.
3. 9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci. Biobehav. Rev. 16, 55-62.
4. 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology 118, 419-424.
5. 9-tetrahydrocannabinol: Mechanistic studies. J. Clin. Pharmacol. 21, 227S-234S.
6. 9-THC in a drug-discrimination procedure. Exp. Clin. Psychopharmacol. 5, 195-202.
7. Compton, D.R., Martin, B.R., 1997. The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J. Pharmacol. Exp. Ther. 283, 1138-1143.
8. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263, 1118-1126.
9. Compton, D.R., Rice, K.C., De Costa, B.R., Razdan, R.K., Melvin, L.S., Johnson, M.R., Martin, B.R., 1993. Cannabinoid structure-activity relationships: Correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265, 218-226.
10. Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A., Gilula, N.B., 1996. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83-87.
11. Crawley, J.N., Corwin, R.L., Robinson, J.K., Felder, C.C., Devane, W.A., Axelrod, J., 1993. Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol. Biochem. Behav. 46, 967-972.
12. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., Mechoulam, R., 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
13. Fride, E., Mechoulam, R., 1993. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur. J. Pharmacol. 231, 313-314.
14. 9-THC and CP 55,940 in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 262, 479-486.
15. James, G.T., 1978. Inactivation of the protease inhibitor phenylmethyl-sulfonyl fluoride in buffers. Anal. Biochem. 86, 574-579.
16. Järbe, T.U.C., Hiltunen, A.J., Mechoulam, R., 1989. Subjectively experienced cannabis effects in animals. Drug Dev. Res. 16, 385-393.
17. Smith, P.B., Compton, D.R., Welch, S.P., Razdan, R.K., Mechoulam, R., Martin, B.R., 1994. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270, 219-227.
18. Tallarida, R.J., Murray, R.B., 1987. Manual of pharmcologic calculations with computer programs, 2nd edn., Springer-Verlag, New York.
19. Wiley, J.L., Golden, K.M., Ryan, W.J., Balster, R.L., Razdan, R.K., Martin, B.R., 1997. Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. Pharmacol. Biochem. Behav. 58, 1139-1143.
20. Wiley, J.L., Balster, R.L., Martin, B.R., 1995a. Discriminative stimulus effects of anandamide in rats. Eur. J. Pharmacol. 276, 49-54.
21. Wiley, J.L., Barrett, R.L., Lowe, J., Balster, R.L., Martin, B.R., 1995b. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34, 669-676.
22. 9-11-tetrahydrocannabinol in rats and rhesus monkeys. Neuropharmacology 32, 359-365.